Company Analysis
Sign in

Alector, Inc. (ALEC)

Nasdaq: ALEC · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2015
Full chart Alerts Compare
Grade3.8
◀ Past 5.9● Present 4.0▶ Future 2.2
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

48 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Alector, Inc.’s names, not what it holds today.

Patents granted
48
48 utility, 1976 to Dec 31, 2025
Granted in 2025
12
Against 7 in 2024 and 4 in 2023
Applications published
104
14 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals22
Biotechnology15
Other special machines1
Analysis of biological materials1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Alector LLC its own name
US, as the owner printed on each patent
48 granted
80 published
Alector LLC its own name
named as the applicant on its applications, in US
0 granted
24 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Jul 15, 202512,358,991Anti-Sortilin antibodies and methods of use thereofPharmaceuticalsAlector LLC
Jun 17, 202512,331,112Anti-MS4A4A antibodies and methods of use thereofBiotechnologyAlector LLC
Jun 17, 202512,331,111Anti-MS4A4A antibodies and methods of use thereofBiotechnologyAlector LLC
Jun 3, 202512,319,734Anti-TMEM106B antibodies and methods of use thereofBiotechnologyAlector LLC
May 13, 202512,297,277Anti-sortilin antibodies and methods of use thereofPharmaceuticalsAlector LLC
Mar 25, 202512,258,410Anti-SIRPα antibodies and methods of use thereofBiotechnologyAlector LLC
Mar 25, 202512,258,398Anti-Siglec-5 antibodies and methods of use thereofPharmaceuticalsAlector LLC
Mar 11, 202512,247,073Anti-CD33 antibodies and methods of use thereofPharmaceuticalsAlector LLC
Feb 18, 202512,227,568Anti-Siglec-7 antibodies and methods of use thereofBiotechnologyAlector LLC
Feb 18, 202512,226,482Anti-SIRP-alpha antibodies and methods of use thereofPharmaceuticalsAlector LLC
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Oct 30, 20252025/0333523Anti-IL18 Binding Protein Antibodies and Methods of Use ThereofBiotechnologyAlector LLC
Sep 25, 20252025/0297016ANTI-SORTILIN ANTIBODIES AND METHODS OF USE THEREOFPharmaceuticalsAlector LLC
Aug 28, 20252025/0270343ANTI-GPNMB ANTIBODIES AND METHODS OF USE THEREOFPharmaceuticalsAlector LLC
Aug 28, 20252025/0270341CD98HC ANTIGEN-BINDING DOMAINS AND USES THEREFORPharmaceuticalsAlector LLC
Aug 28, 20252025/0270339TRANSFERRIN RECEPTOR ANTIGEN-BINDING DOMAINS AND USES THEREFORPharmaceuticalsAlector LLC
Aug 28, 20252025/0270319ANTI-CD33 ANTIBODIES AND METHODS OF USE THEREOFPharmaceuticalsAlector LLC
Jul 10, 20252025/0223365METHODS OF USE OF ANTI-SORTILIN ANTIBODIESPharmaceuticalsAlector LLC
Jun 5, 20252025/0179189Anti-SIRPa Antibodies and Methods of Use ThereofBiotechnologyAlector LLC
May 8, 20252025/0145709ANTI-SIGLEC-7 ANTIBODIES AND METHODS OF USE THEREOFBiotechnologyAlector LLC
May 8, 20252025/0144209Anti-SIRP-Alpha Antibodies and Methods of Use ThereofPharmaceuticalsAlector LLC
What it applied for, 2024 to 2025: Pharmaceuticals 21 · Biotechnology 11 · Analysis of biological materials 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton ALEC · research, not advice